Navigation Links
Law Offices of Howard G. Smith Announces Class Action Lawsuit Against LCA-Vision Inc.
Date:9/17/2007

BENSALEM, Penn., Sept. 17 /PRNewswire/ -- Law Offices of Howard G. Smith announces that a securities class action lawsuit has been filed on behalf of shareholders who purchased the common stock of LCA-Vision Inc. ("LCA-Vision" or the "Company") (Nasdaq: LCAV) between February 12, 2007 and July 30, 2007 (the "Class Period"). The class action lawsuit was filed in the United States District Court for the Southern District of Ohio.

The Complaint alleges that defendants violated federal securities laws by issuing material misrepresentations to the market concerning the Company's business and financial performance, thereby artificially inflating the price of LCA-Vision securities.

No class has yet been certified in the above action. Until a class is certified, you are not represented by counsel unless you retain one. If you purchased LCA-Vision shares between February 12, 2007 and July 30, 2007, you have certain rights, and have until November 12, 2007, to move for Lead Plaintiff status. To be a member of the class you need not take any action at this time, and you may retain counsel of your choice. If you wish to discuss this action or have any questions concerning this Notice or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020, by telephone at (215)638-4847, Toll-Free at (888)638-4847, by email to howardsmithlaw@hotmail.com or visit our website at http://www.howardsmithlaw.com.


'/>"/>
SOURCE Law Offices of Howard G. Smith
Copyright©2007 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Gigantic Effort: Smoking To Be Banned in British Telecom’s Offices and Van
2. Smoking to be Prohibited at Public Offices in Bangkok from 2008
3. GlaxoSmithKline - Changes Lamictal(R) Label Appearance and Packaging
4. Iodex goes to SmithKline Beecham consumer Healthcare
5. GlaxoSmithKline To Cultivate Non-Smoking Environment
6. GlaxoSmithKline to Supply United States with 8 Million flu vaccine, Fluarix
7. FDA Mislead On Asthma Drug By GlaxoSmithKline
8. GlaxoSmithKline Defends Its Products
9. GlaxoSmithKline launches diabetes and cancer drugs
10. Generic Products Compete With GlaxoSmithKline
11. New Cervical Cancer Vaccine to Be Launched By Glaxo Smithkline
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... ... December 07, 2016 , ... Silhouette Instalift is a simple, ... and tightening the skin of the face to create more youthful features. While ... very little downtime, Silhouette Instalift is a novel, minimally invasive facial procedure that ...
(Date:12/7/2016)... ... 07, 2016 , ... In the early morning of October 30, Newton County ... when he lost control of his patrol car. The vehicle overturned into an embankment, ... transported to Atlanta Medical Center, where he later succumbed to his injuries. Justin White ...
(Date:12/7/2016)... ... December 07, 2016 , ... Levels of a protein ... according to a study appearing online in the journal Radiology. , Heart disease and ... increase significantly due to the rapidly aging population. Damage to both organs often occurs ...
(Date:12/7/2016)... ... 07, 2016 , ... The Cliff Hart Agencies, a Michigan-based ... Dewitt, Williamston, East Lansing, Ann Arbor, and Farmington Hills, is announcing a regional ... tumor. , Jason Bauer and his family are longtime members of the Williamston ...
(Date:12/7/2016)... (PRWEB) , ... December 07, 2016 , ... AlignLife clinics ... Many children are not fortunate enough to receive bountiful gifts wrapped tightly under ... presents can bring to the children of the world. , In exchange for generous ...
Breaking Medicine News(10 mins):
(Date:12/7/2016)... YORK , Dec. 7, 2016 ... report on pulmonary drugs studies the current as ... The stakeholders of this report include companies and ... various pulmonary/respiratory drugs and/or drug-device combinations as well ... This report comprises an elaborate executive summary along ...
(Date:12/7/2016)... , Dec. 7, 2016  The Corporate Whistleblower ... manager to call them anytime at 866-714-6466 if they ... to sell more drugs. Aside from the innocent patients ... as well, because often-times these practices target Medicare recipients or ... ...
(Date:12/7/2016)... Conn. , Dec. 7, 2016 According to ... in more than one-third (38%) of patients with non-small cell ... epidermal growth factor receptor (EGFR) genetic mutation status. The findings ... ( LBA ID #6067 #P3.02b ) at the ... Vienna, Austria . The survey results revealed ...
Breaking Medicine Technology: